Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
3.
Inflamm Bowel Dis ; 2023 Feb 15.
Article in English | MEDLINE | ID: covidwho-2239482

ABSTRACT

We evaluated antibody concentrations 6 months after a third coronavirus disease 2019 messenger RNA vaccine dose in patients with inflammatory bowel diseases. Almost all patients had an antibody response, and those with a previous SARS-CoV-2 infection had higher antibody concentrations.

6.
Inflamm Bowel Dis ; 28(11): 1781-1786, 2022 11 02.
Article in English | MEDLINE | ID: covidwho-1784354

ABSTRACT

Herein, we evaluated the humoral immunogenicity of a third coronavirus disease 2019 messenger RNA vaccine dose in patients with inflammatory bowel diseases. All patients displayed a humoral immune response, and median antibody concentrations were higher after the third dose than after completion of the 2-dose series.


Subject(s)
COVID-19 , Colitis, Ulcerative , Inflammatory Bowel Diseases , Humans , COVID-19 Vaccines , RNA, Messenger , Colitis, Ulcerative/genetics
SELECTION OF CITATIONS
SEARCH DETAIL